P218-2756 Screening compound: 2-(3-chlorophenyl)-5-(2,3-dihydro-1,4-benzodioxine-6-sulfonyl)-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine

P218-2756 Screening compound: 2-(3-chlorophenyl)-5-(2,3-dihydro-1,4-benzodioxine-6-sulfonyl)-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine
P218-2756 Screening compound: 2-(3-chlorophenyl)-5-(2,3-dihydro-1,4-benzodioxine-6-sulfonyl)-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine alternative view

Chemical Structure Depiction of ChemDiv screening compound P218-2756
2-(3-chlorophenyl)-5-(2,3-dihydro-1,4-benzodioxine-6-sulfonyl)-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P218-2756

Molecular Formula

C21H20ClN3O4S (C21 H20 ClN3 O4 S)

Compound Name

2-(3-chlorophenyl)-5-(2,3-dihydro-1,4-benzodioxine-6-sulfonyl)-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine

IUPAC name

2-(3-chlorophenyl)-5-(23-dihydro-14-benzodioxine-6-sulfonyl)-4H5H6H7H8H-pyrazolo[15-a][14]diazepine

SMILES

O=S(c(cc1)cc2c1OCCO2)(N1Cc2cc(-c3cccc(Cl)c3)nn2CCC1)=O

InChI

InChI=1S/C21H20ClN3O4S/c22-16-4-1-3-15(11-16)19-12-17-14-24(7-2-8-25(17)23-19)30(26,27)18-5-6-20-21(13-18)29-10-9-28-20/h1,3-6,11-13H,2,7-10,14H2

InChI Key

PKXXIHYGWUPQHD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27569604

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

445.93

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.031

Distribution Coefficient, logD

3.031

Water Solubility, LogSw

-3.53

Polar Surface Area

61.303

Acid Dissociation Constant (pKa)

26.51

Base Dissociation Constant (pKb)

-1.10

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.60

P218-2756 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Allosteric Kinases Inhibitors Library (23117 compounds)

Anticancer Library (62698 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

New Agro Library (44492 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds
  • Mimetics
Agro:
  • Agro

References: we are preparing a list of scientific research reports with P218-2756 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P218-2756?
Check Price and Availability of P218-2756, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P218-2756 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P218-2756
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P218-2756
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P218-2756 available by request